Objective to observe the curative effect of oral capsule Xuezhikang on the elder patients with Coronary Heart Disease Angina Pectoris combined by high blood lipid.
目的观察口服血脂康胶囊对老年人冠心病心绞痛并血脂异常患者降脂作用的临床疗效。
Objective Observe the changes of main efficacy of Dachuanxiong soft capsule changed from Dachuanxiong oral liquid.
目的观察将大川芎口服液改成大川芎软胶囊后的药效学变化。
Type of Products: capsule, capsule plate, granule, pill, Oral Liquid, tablet, tablet plate etc.
产品剂型：胶囊型、胶囊压板、颗粒剂、丸剂、口服液、片剂、片剂压板等。
Methods Taking the antivirus experiment in vitro with rats' serum after the oral administration of antivirus capsule.
方法取口饲抗病毒胶囊后的大鼠血清进行体外抗病毒作用实验。
Tongbiantong capsule, an oral preparation for colon site-specific drug delivery, is anew remedy for constipation.
新药通便通胶囊是一种治疗便秘的口服结肠靶向给药制剂。
The invention relates to a taxol double-layer soft capsule oral preparation medicament.
本发明涉及一种紫杉醇类双层软胶囊口服制剂药物。
The pharmaceutical composition can be prepared into tablet, dispersible tablet, oral disintegrating tablet or capsule.
该药物组合物以片剂、分散片、口腔崩解片及胶囊的形式存在。
Our pharmaceuticals include such as tablets, capsule, mixture, oral solution, injection solution etc. with totally 154 kinds of listed products.
医药产品包括片剂、胶囊、合剂、口服液、注射液等多种剂型，国药准字154个品种。
Control group to give oral faeries bone remains capsule; The treatment group give temperature treatment, and cooperate with needle spleen keep bone soup oral.
对照组给予口服仙灵骨葆胶囊，治疗组给予温针治疗，并配合健脾养骨汤口服。
It is indicates that the concentrated capsule of 1, 25-dihydroxyvitamin D3 oral preparation would be in favor of absorption and utilization.
这提示1,25二羟基维生素d 3口服制剂的浓缩剂型，将有利于其吸收利用。
Conclusion: the therapeutic effect of acupuncture on non-premonitory migraine is better than that of oral administration of flunarizine hydrochloride capsule.
结论：针刺治疗不伴先兆偏头痛的疗效优于口服盐酸氟桂嗪胶囊。
CONCLUSIONS the pharmacokinetic parameters of flupirtine maleate in healthy volunteers after an oral single dose of flupirtine maleate capsule is concordant with that of the literature.
结论健康受试者单剂量口服马来酸氟吡汀胶囊的药动学参数与文献报道基本一致。
The indirubin derivative and pharmaceutically acceptable supplementary material may be prepared into tablet, capsule or other oral preparation.
靛玉红衍生物与药学上允许的辅料加工成片剂、胶囊剂等口服制剂。
Methods 56 patients with IR and fat metabolism disorder were randomly given oral dimethyldiguanide (group A) and Gliclazide capsule (group B) for 3 months.
方法将符合IR及脂代谢紊乱诊断的2型糖尿病患者56例随机分别予口服二甲双胍（A组）、格列齐特（B组）治疗3个月。
Methods 56 patients with IR and fat metabolism disorder were randomly given oral dimethyldiguanide (group A) and Gliclazide capsule (group B) for 3 months.
方法将符合IR及脂代谢紊乱诊断的2型糖尿病患者56例随机分别予口服二甲双胍（A组）、格列齐特（B组）治疗3个月。
应用推荐